Vicario R et al. detected that HER2 amplification in DMs or in HSR occurs in 30 and 60% of HER2-positive breast cancers, respectively, indicating that different mechanisms of HER2 gene amplification exist in breast cancer.232. Here, ERBB2 is linked to breast carcinoma.